A Review of Drugs for Treatment of Alzheimer’s Disease in Clinical Trials: Main Trends

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova - Russian Federation
doi 10.17116/jnevro20161168177-87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Physical Therapy in Patients With Alzheimer’s Disease: A Systematic Review of Randomized Controlled Clinical Trials

Fisioterapia e Pesquisa
2019English

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

Neurotherapeutics
NeurologyPharmacology
2016English

Print Advertisements for Alzheimer’s Disease Drugs

American Journal of Alzheimer's Disease and other Dementias
GerontologyClinical PsychologyMental HealthGeriatricsPsychiatryNeuroscience
2013English

A Template for New Drugs Against Alzheimer’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2013English

Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease

Open Journal of Neuroscinece
2013English

Genomics Drugs in Clinical Trials

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2010English

Recruitment, Retention and Other Methodological Issues Related to Clinical Trials for Alzheimer’s Disease

Journal of Nutrition, Health and Aging
MedicineNutritionGerontologyGeriatricsDietetics
2012English

Pharmacokinetics of a Novel Transdermal Rivastigmine Patch for the Treatment of Alzheimer’s Disease: A Review

International Journal of Clinical Practice
Medicine
2009English

Trends in Pragmatic Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy